Robert Burns
Stock Analyst at HC Wainwright & Co.
(3.87)
# 633
Out of 5,147 analysts
479
Total ratings
45.64%
Success rate
11.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORIC ORIC Pharmaceuticals | Maintains: Buy | $23 → $25 | $13.45 | +85.87% | 27 | Feb 24, 2026 | |
| KPTI Karyopharm Therapeutics | Reiterates: Buy | $15 | $9.41 | +59.40% | 4 | Feb 18, 2026 | |
| EXEL Exelixis | Maintains: Buy | $52 → $54 | $44.06 | +22.56% | 15 | Feb 12, 2026 | |
| HURA TuHURA Biosciences | Reiterates: Buy | $10 | $1.67 | +498.80% | 5 | Feb 3, 2026 | |
| CATX Perspective Therapeutics | Maintains: Buy | $10 → $12 | $5.40 | +122.22% | 6 | Jan 30, 2026 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $31 → $32 | $15.97 | +100.38% | 21 | Jan 29, 2026 | |
| CRDF Cardiff Oncology | Reiterates: Buy | $10 | $1.94 | +415.46% | 4 | Jan 28, 2026 | |
| MOLN Molecular Partners AG | Initiates: Buy | $13 | $5.02 | +158.83% | 2 | Jan 27, 2026 | |
| ACET Adicet Bio | Maintains: Buy | $9 → $50 | $7.25 | +589.66% | 3 | Jan 21, 2026 | |
| TLX Telix Pharmaceuticals | Reiterates: Buy | $20 | $7.25 | +175.86% | 4 | Jan 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $17 | $5.91 | +187.65% | 18 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $15.50 | +74.19% | 4 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $52 | $38.85 | +33.85% | 16 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $8.07 | +48.70% | 10 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $32 | $23.29 | +37.40% | 23 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $136 → $140 | $110.23 | +27.01% | 46 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $102.02 | -28.45% | 21 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $9 | $1.90 | +373.68% | 15 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $2 | $1.99 | +0.50% | 22 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.48 | +237.84% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $7.65 | +56.86% | 20 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $7 | $4.52 | +54.87% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $4.10 | +70.73% | 22 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.76 | +81.16% | 17 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $10.03 | +169.19% | 1 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $2.71 | +1,154.61% | 4 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $10.26 | +36.45% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $16.78 | +138.38% | 5 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $42 | $22.97 | +82.85% | 11 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $2.47 | +304.86% | 14 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $12.99 | +0.08% | 8 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $29.69 | +61.67% | 5 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $11.14 | +16.70% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.70 | +194.12% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $2.78 | +187.77% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $5.42 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $20.21 | +889.61% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $0.79 | +30,101.98% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.48 | +31,280.75% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $5.37 | +104.84% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $2.17 | +2,073,632.72% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.71 | +660.23% | 1 | Jan 7, 2021 |
ORIC Pharmaceuticals
Feb 24, 2026
Maintains: Buy
Price Target: $23 → $25
Current: $13.45
Upside: +85.87%
Karyopharm Therapeutics
Feb 18, 2026
Reiterates: Buy
Price Target: $15
Current: $9.41
Upside: +59.40%
Exelixis
Feb 12, 2026
Maintains: Buy
Price Target: $52 → $54
Current: $44.06
Upside: +22.56%
TuHURA Biosciences
Feb 3, 2026
Reiterates: Buy
Price Target: $10
Current: $1.67
Upside: +498.80%
Perspective Therapeutics
Jan 30, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $5.40
Upside: +122.22%
Nurix Therapeutics
Jan 29, 2026
Maintains: Buy
Price Target: $31 → $32
Current: $15.97
Upside: +100.38%
Cardiff Oncology
Jan 28, 2026
Reiterates: Buy
Price Target: $10
Current: $1.94
Upside: +415.46%
Molecular Partners AG
Jan 27, 2026
Initiates: Buy
Price Target: $13
Current: $5.02
Upside: +158.83%
Adicet Bio
Jan 21, 2026
Maintains: Buy
Price Target: $9 → $50
Current: $7.25
Upside: +589.66%
Telix Pharmaceuticals
Jan 21, 2026
Reiterates: Buy
Price Target: $20
Current: $7.25
Upside: +175.86%
Jan 12, 2026
Maintains: Buy
Price Target: $18 → $17
Current: $5.91
Upside: +187.65%
Jan 8, 2026
Maintains: Buy
Price Target: $26 → $27
Current: $15.50
Upside: +74.19%
Jan 6, 2026
Maintains: Buy
Price Target: $50 → $52
Current: $38.85
Upside: +33.85%
Dec 9, 2025
Maintains: Buy
Price Target: $8 → $12
Current: $8.07
Upside: +48.70%
Nov 18, 2025
Maintains: Buy
Price Target: $26 → $32
Current: $23.29
Upside: +37.40%
Nov 10, 2025
Maintains: Buy
Price Target: $136 → $140
Current: $110.23
Upside: +27.01%
Nov 6, 2025
Maintains: Buy
Price Target: $72 → $73
Current: $102.02
Upside: -28.45%
Nov 5, 2025
Maintains: Buy
Price Target: $3 → $9
Current: $1.90
Upside: +373.68%
Nov 3, 2025
Reiterates: Neutral
Price Target: $2
Current: $1.99
Upside: +0.50%
Oct 31, 2025
Upgrades: Buy
Price Target: $5
Current: $1.48
Upside: +237.84%
Oct 27, 2025
Upgrades: Buy
Price Target: $12
Current: $7.65
Upside: +56.86%
Oct 20, 2025
Assumes: Buy
Price Target: $7
Current: $4.52
Upside: +54.87%
Oct 16, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $4.10
Upside: +70.73%
Sep 23, 2025
Reiterates: Buy
Price Target: $5
Current: $2.76
Upside: +81.16%
Sep 15, 2025
Initiates: Buy
Price Target: $27
Current: $10.03
Upside: +169.19%
Aug 26, 2025
Reiterates: Buy
Price Target: $34
Current: $2.71
Upside: +1,154.61%
Aug 26, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $10.26
Upside: +36.45%
Aug 22, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $16.78
Upside: +138.38%
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $22.97
Upside: +82.85%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.47
Upside: +304.86%
Jul 17, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $12.99
Upside: +0.08%
Jul 2, 2025
Maintains: Buy
Price Target: $40 → $48
Current: $29.69
Upside: +61.67%
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $11.14
Upside: +16.70%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.70
Upside: +194.12%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $2.78
Upside: +187.77%
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.42
Upside: -
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $20.21
Upside: +889.61%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $0.79
Upside: +30,101.98%
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $0.48
Upside: +31,280.75%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $5.37
Upside: +104.84%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $2.17
Upside: +2,073,632.72%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.71
Upside: +660.23%